{"id":1068242,"date":"2022-12-24T00:13:12","date_gmt":"2022-12-24T05:13:12","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/cellectis-announces-first-dosing-of-a-patient-with-its-in-house-manufactured-product-candidate-ucart22-for-the-treatment-of-r-r-b-cell-all\/"},"modified":"2024-08-18T11:44:49","modified_gmt":"2024-08-18T15:44:49","slug":"cellectis-announces-first-dosing-of-a-patient-with-its-in-house-manufactured-product-candidate-ucart22-for-the-treatment-of-r-r-b-cell-all","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cellectis-announces-first-dosing-of-a-patient-with-its-in-house-manufactured-product-candidate-ucart22-for-the-treatment-of-r-r-b-cell-all.php","title":{"rendered":"Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22\u00a0for the treatment of r\/r B-cell ALL"},"content":{"rendered":"<p><![CDATA[NEW YORK, Dec.  22, 2022  (GLOBE NEWSWIRE) -- Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that for the first time, a patient was dosed in the United States with its in-house manufactured product candidate UCART22, and completed the 28 day DLT period on December 14th, 2022, without complication.]]><\/p>\n<p>Read this article:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/12\/22\/2578926\/0\/en\/Cellectis-Announces-First-Dosing-of-a-Patient-with-its-In-house-Manufactured-Product-Candidate-UCART22-for-the-treatment-of-r-r-B-cell-ALL.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22\u00a0for the treatment of r\/r B-cell ALL\">Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22\u00a0for the treatment of r\/r B-cell ALL<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read this article: Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22\u00a0for the treatment of r\/r B-cell ALL <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cellectis-announces-first-dosing-of-a-patient-with-its-in-house-manufactured-product-candidate-ucart22-for-the-treatment-of-r-r-b-cell-all.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068242","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068242"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068242"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068242\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}